Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Hilton Lac-Leamy

Oct 27, 2025 7:30 AM - Oct 28, 2025 3:40 PM

3 Boulevard du Casino, Gatineau, QC J8Y 6X4, Canada

Canada Annual Meeting

The Canada Annual Meeting offers three tracks, Regulatory, Clinical, Safety and Pharmacovigilance!

Session 3, Track A: Evolution of Labelling

Session Chair(s)

Amber  McLeod, PhD

Amber McLeod, PhD

Immunology, Virology, and Specialty Head, Regulatory Affairs

Abbvie Corporation, Canada

Marcia  Sam

Marcia Sam

Senior Manager, Regulatory Affairs

Regeneron Canada Company, Canada

This session will focus on the latest trends and challenges in product labeling, with an emphasis on technological advancements, regulatory compliance, and inclusive communication practices. Attendees will explore the evolving landscape of digital medication information dissemination and gain insights into e-labelling approaches and new risk-based methodology being applied for regulatory compliance. Furthermore, the session will provide insights on adopting gender-inclusive language in labeling to promote equitable and respectful consumer communication. This discussion aims to provide participants with the knowledge and tools needed to effectively navigate and adapt to current and future labeling practices.

  • Electronic Patient Medication Information (ePMIs) – Where are We Now?
    Neerja Goyal, GlaxoSmithKline, Inc.
  • Words Matter: Adopting Gender Inclusive Language in Product Labelling
    Adesola Adeyemi, BAYER INC.
  • Pharmaceutical Drug Directorate Paper Package Insert Waiver Assessment Process
    Amanda Starr, Health Canada

Learning Objective :

At the conclusion of this session, participants should be able to:

  • Describe the current developments in product labelling as a result of changing technology and regulatory compliance
  • Explain how patients and industry will benefit from utilizing technology
  • Identify how to incorporate gender-inclusive language into labelling to enhance patient communication

Speaker(s)

Amanda  Starr, PhD

Pharmaceutical Drug Directorate Paper Package Insert Waiver Assessment Process

Amanda Starr, PhD

Health Canada, Canada

Scientific Evaluator - Pharmaceutical Drugs Directorate

Neerja  Goyal, MS

Electronic Patient Medication Information (ePMIs) – Where are We Now?

Neerja Goyal, MS

GlaxoSmithKline, Inc., Canada

Director, Regulatory Strategy and Policy

Adesola  Adeyemi, MSc

Words Matter: Adopting Gender Inclusive Language in Product Labelling

Adesola Adeyemi, MSc

Bayer Inc., Canada

Regulatory Affairs Project Manager, Bayer Inc. Canada

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.